Asahi Life Asset Management’s Boston Scientific BSX Stock Holding History

Asahi Life Asset Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-6,226	Closed	-$594K	–	159
2025 Q4	$594K	Buy	6,226 +3,589	+136%	+$352K	0.33%	61
2025 Q3	$257K	Buy	+2,637	New	+$273K	0.14%	148
2021 Q4	–	Sell	-5,580	Closed	-$242K	–	198
2021 Q3	$242K	Sell	5,580 -6,210	-53%	-$275K	0.03%	154
2021 Q2	$504K	Buy	+11,790	New	+$496K	0.07%	80

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Asahi Life Asset Management's BSX Position: Q1 2026 in Review

Asahi Life Asset Management sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 6,226 shares — an estimated $594K sold.

Asahi Life Asset Management first reported a position in BSX in Q2 2021 and held it in 4 quarters. The position peaked at $594K in Q4 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Asahi Life Asset Management reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
Asahi Life Asset Management sold 6,226 Boston Scientific shares in Q1 2026, an estimated $594K.
Asahi Life Asset Management first reported a position in Boston Scientific in Q2 2021 and held it in 4 quarters.
Asahi Life Asset Management's Boston Scientific position peaked at $594K in Q4 2025.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Asahi Life Asset Management's 13F filing for Q1 2026, filed 27 Apr 2026.